Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lux Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Lux Biosciences

Lux Biosciences

Acquired

Biotech firm, Lux Biosciences, innovates and commercializes treatments for severe ophthalmic diseases in the US.

HQ
Jersey City, NJ, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Lux Biosciences, founded to address unmet needs in ophthalmic care, is a clinical-stage biotechnology company focused on developing and commercializing medications for serious eye diseases. The company's core mission is to improve the quality of life for patients suffering from severe ophthalmic conditions through innovative treatments. Lux Biosciences primarily serves the United States market, targeting both patients and healthcare providers with its specialized therapeutic solutions.

Notable affiliated individuals and investors in Lux Biosciences include key figures from the biotechnology and pharmaceutical sectors, although specific names are not provided. The company has achieved significant milestones in advancing its clinical trials and securing regulatory approvals for its products. Lux Biosciences' impact is evident in its commitment to addressing critical gaps in ophthalmic care, contributing to the overall advancement of medical treatments for eye diseases.

Lux Biosciences - Similar Companies

Visiox logo

Visiox

visioxpharma.com

Qlaris Bio logo

Qlaris Bio

qlaris.bio

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Ocular Science logo

Ocular Science

ocularscience.com

Imagen Biotech logo

Imagen Biotech

Lumen Bioscience logo

Lumen Bioscience

EyeCyte logo

EyeCyte

eyecyte.com

Lenticular Research Group logo

Lenticular Research Group

Brii Biosciences logo

Brii Biosciences

briibio.com

Harmony Biosciences logo

Harmony Biosciences

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Superior Biologics logo

Superior Biologics

LumiThera logo

LumiThera

lumithera.com

Lux Biosciences - Quick Facts

Who are Lux Biosciences' competitors?

Companies similar to Lux Biosciences include Visiox, Qlaris Bio, Aurion Biotech and Ocular Science.

When was Lux Biosciences founded?

Lux Biosciences was founded in 2005.

Where is Lux Biosciences' headquarters located?

Lux Biosciences' headquarters is located in Jersey City, NJ, US.

When was Lux Biosciences' last funding round?

Lux Biosciences' most recent funding round was for $16M (USD) in March 2012.

How much has Lux Biosciences raised to-date?

As of Mar 6, 2012, Lux Biosciences has raised a total of $129.2M (USD).

Lux Biosciences - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified